Key facts
- It has raised $1.6M; the latest was Grant ($3.0M) in Oct 2025.
- Notable investors include US National Science Foundation, MedTech Innovator, National Institutes of Health, Virginia Venture Partners, Alex Euler — 15 tracked in total.
- Status: Privately Held (backing).
Investors
15+- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Rivanna
- ·The full record, as it builds
Funding rounds
No funding rounds for Rivanna are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rivanna
Developer of an ultrasound-based system designed to offer a medical imaging device for automated measurements of the spinal midline. The company's system uses automated three-dimensional navigation technology for ultrasound imaging, enabling anesthesia providers to apply spinal and epidural anesthesia effortlessly.
- Sector
- Healthcare
- HQ
- Charlottesville, VA, United States
- Founded
- 2010
- Employees
- 26
- Website
- rivannamedical.com/
- Ownership
- Privately Held (backing)
Rivanna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rivanna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rivanna in its N-PORT filings yet. We sweep new filings monthly.